The report, released Monday, predicts 10 top growth opportunities in the industry and suggests that, with the healthcare consumerism boom, global revenues will hit $2.7 trillion by 2025.
According to a Frost & Sullivan analysis, adverse patient safety events cost the U.S. and European healthcare systems $317.93 billion in 2016. By 2022, the analysis estimates that amount will rise to $383.7 billion.
A new Frost and Sullivan report suggests that post-acute care facilities could strengthen their positions in an increasingly competitive landscape by integrating continuous monitoring technology and improving the outcome of high acuity patients.
A new Frost & Sullivan report predicts biometrics will be a mainstream feature of cars by 2025 from fatigue alerts to preventing drivers from nodding off.
That estimate comes from a new, lengthy and pricey report by research firm Frost & Sullivan on the U.S. market for hospital cybersecurity.
Rural hospitals have been particularly hard hit in the states that did not expand Medicaid coverage to more citizens.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The ripple-effect of last week’s 23andMe news is just the beginning. A new study and an important genomics conference will only further highlight the opportunities coming in personalized medicine. New analysis from Frost & Sullivan, Future of Personalized Genomics, shows that genetic tests provided by companies straight to consumers via the e-commerce platform are more affordable […]
Data security, RFID installations, solar power, air quality data, and the Internet of Things — I don’t think you could find any more buzzwords to describe our August Hangout. The topic is the Internet of Things in healthcare, but we won’t be talking about an Industrial Internet that is 10 (or 15 or 20) years […]
A new Frost & Sullivan report calls attention to a new chapter in printing technology making its way into healthcare called 4D printing. The biggest difference from 3D printing is 4D involves technologies that alter the properties and behaviors of objects such as external stimuli such as changes in temperature. They can also, to a […]
A digital health company that developed an API to free data from mobile health apps, wearables and monitoring devices received an award recognizing its accomplishments from Frost & Sullivan. It presented Validic with its best practices award for customer value leadership. Frost & Sullivan Research Analyst Shruthi Parakkal praised the company especially for its potential […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The infusion or “smart” pumps market will grow more than a billion dollars from its 2012 value–$3.17 billion–to its 2019 worth–$4.26 billion, according to a report from Frost & Sullivan. Even taking reimbursement issues into account, ambulatory and insulin pumps should see significant growth over the next several years, according to new research from Frost […]
When Medtronic announced its acquisition of Cardiocom earlier this week, it was a big (and loud) move in shaping the company’s “now we’re a healthcare service provider” strategy. But Cardiocom only makes $40 to $50 million in revenue, relatively small potatoes for a titan like Medtronic. What does this announcement mean, really, then? “The importance […]
In conversations with entrepreneurs starting or running companies in the women’s health space, I’ve heard a few of the same major challenges echoed: there’s not enough research, not enough education/awareness and not enough funding. A new report from research firm Frost & Sullivan proposes that collaboration between public and private sectors is a critical factor […]
St. Jude's purchase of Advanced Neuromodulation Systems In Texas has given the Minnesota medical device maker a much-needed boost in revenue at a time when global demand for mechanical heart devices starts to wane.
